{"id":9891,"date":"2018-05-03T15:23:10","date_gmt":"2018-05-03T15:23:10","guid":{"rendered":"https:\/\/sbpt.org.br\/portal\/?p=9891"},"modified":"2018-05-03T15:23:10","modified_gmt":"2018-05-03T15:23:10","slug":"caso-clinico-marco-2018","status":"publish","type":"post","link":"https:\/\/sbpt.org.br\/portal\/caso-clinico-marco-2018\/","title":{"rendered":"Caso cl\u00ednico \u2013 Mar\u00e7o 2018"},"content":{"rendered":"<p><strong>Discutindo o tratamento farmacol\u00f3gico da DPOC<\/strong><\/p>\n<p><strong>Autores<\/strong><\/p>\n<p>Dr. Paulo Jos\u00e9 Zimmermann Teixeira &#8211; Professor da Faculdade de Medicina da UFCSPA.<br \/>\nMarcelo Ferreira Nogueira &#8211; Residente em Pneumologia da ISCMPA.<br \/>\nMateus Henrique Schneider &#8211; Acad\u00eamico da Faculdade de Medicina da UFCSPA.<\/p>\n<p><strong>Relato do Caso<\/strong><\/p>\n<p><strong>Parte 1<\/strong><\/p>\n<p>Paciente feminina, 73 anos, ex-tabagista (fumou dos 13 aos 63 anos, 15 cigarros\/dia = 37.5 ma\u00e7os\/ano), refere dispneia progressiva h\u00e1 8 anos, atualmente MRC (Medical Research Council) n\u00edvel 3 e epis\u00f3dio de TEP em 1990. Ocorr\u00eancia de um epis\u00f3dio de exacerba\u00e7\u00e3o com necessidade de antibioticoterapia no \u00faltimo ano. Refere tosse produtiva intensificada no inverno e eventuais sibilos com in\u00edcio h\u00e1 dois anos. Fazia uso irregular de Formoterol + Budesonida, nebuliza\u00e7\u00f5es com Fenoterol + Ipatr\u00f3prio, Omeoprazol 20 mg e Fluoxetina 20 mg diariamente.<\/p>\n<p>Ao exame f\u00edsico, bom estado geral, l\u00facida, orientada, consciente e sem sinais de cianose ou hipocratismo digital. Peso de 71 kg e altura de 1.58 m (IMC de 28,44 kg\/m2). Ausculta card\u00edaca com bulhas normofon\u00e9ticas, ritmo regular em dois tempos e sem sopros. Ausculta pulmonar com murm\u00farios vesiculares difusamente reduzidos. Abd\u00f4men sem altera\u00e7\u00f5es. Membros apresentando boa perfus\u00e3o e sem presen\u00e7a de edema perif\u00e9rico.<\/p>\n<p>Espirometria inicial com CVF = 2.36 (91% do previsto), VEF1 = 1.08 L (53% do previsto), VEF1\/CVF = 46 (56% do previsto), PEF = 4.07 (79% do previsto), CPT = 4.69 (106% do previsto), CI = 1.56, VR = 2.11 (116% do previsto) e DLCO = 2.8 (45% do previsto).<\/p>\n<p>Ao exame radiogr\u00e1fico e \u00e0 tomografia computadorizada, a paciente apresenta extensas \u00e1reas enfisematosas comprometendo ter\u00e7o m\u00e9dio e ter\u00e7o superior bilateralmente (figuras 1 a 7).<\/p>\n<figure id=\"attachment_9896\" aria-describedby=\"caption-attachment-9896\" style=\"width: 400px\" class=\"wp-caption aligncenter\"><img loading=\"lazy\" decoding=\"async\" class=\"wp-image-9896 size-full\" src=\"https:\/\/d1xe7tfg0uwul9.cloudfront.net\/sbpt.org.br\/portal\/wp-content\/uploads\/2018\/05\/caso03_mar18_01.jpg\" alt=\"\" width=\"400\" height=\"328\" srcset=\"https:\/\/d1xe7tfg0uwul9.cloudfront.net\/sbpt.org.br\/portal\/wp-content\/uploads\/2018\/05\/caso03_mar18_01.jpg 400w, https:\/\/d1xe7tfg0uwul9.cloudfront.net\/sbpt.org.br\/portal\/wp-content\/uploads\/2018\/05\/caso03_mar18_01-300x246.jpg 300w\" sizes=\"auto, (max-width: 400px) 100vw, 400px\" \/><figcaption id=\"caption-attachment-9896\" class=\"wp-caption-text\">Figura 1<\/figcaption><\/figure>\n<figure id=\"attachment_9897\" aria-describedby=\"caption-attachment-9897\" style=\"width: 400px\" class=\"wp-caption aligncenter\"><img loading=\"lazy\" decoding=\"async\" class=\"wp-image-9897 size-full\" src=\"https:\/\/d1xe7tfg0uwul9.cloudfront.net\/sbpt.org.br\/portal\/wp-content\/uploads\/2018\/05\/caso03_mar18_02.jpg\" alt=\"\" width=\"400\" height=\"456\" srcset=\"https:\/\/d1xe7tfg0uwul9.cloudfront.net\/sbpt.org.br\/portal\/wp-content\/uploads\/2018\/05\/caso03_mar18_02.jpg 400w, https:\/\/d1xe7tfg0uwul9.cloudfront.net\/sbpt.org.br\/portal\/wp-content\/uploads\/2018\/05\/caso03_mar18_02-263x300.jpg 263w\" sizes=\"auto, (max-width: 400px) 100vw, 400px\" \/><figcaption id=\"caption-attachment-9897\" class=\"wp-caption-text\">Figura 2<\/figcaption><\/figure>\n<p>&nbsp;<\/p>\n<figure id=\"attachment_9898\" aria-describedby=\"caption-attachment-9898\" style=\"width: 400px\" class=\"wp-caption aligncenter\"><img loading=\"lazy\" decoding=\"async\" class=\"size-full wp-image-9898\" src=\"https:\/\/d1xe7tfg0uwul9.cloudfront.net\/sbpt.org.br\/portal\/wp-content\/uploads\/2018\/05\/caso03_mar18_03.jpg\" alt=\"\" width=\"400\" height=\"258\" srcset=\"https:\/\/d1xe7tfg0uwul9.cloudfront.net\/sbpt.org.br\/portal\/wp-content\/uploads\/2018\/05\/caso03_mar18_03.jpg 400w, https:\/\/d1xe7tfg0uwul9.cloudfront.net\/sbpt.org.br\/portal\/wp-content\/uploads\/2018\/05\/caso03_mar18_03-300x194.jpg 300w\" sizes=\"auto, (max-width: 400px) 100vw, 400px\" \/><figcaption id=\"caption-attachment-9898\" class=\"wp-caption-text\">Figura 3<\/figcaption><\/figure>\n<p>&nbsp;<\/p>\n<figure id=\"attachment_9899\" aria-describedby=\"caption-attachment-9899\" style=\"width: 400px\" class=\"wp-caption aligncenter\"><img loading=\"lazy\" decoding=\"async\" class=\"size-full wp-image-9899\" src=\"https:\/\/d1xe7tfg0uwul9.cloudfront.net\/sbpt.org.br\/portal\/wp-content\/uploads\/2018\/05\/caso03_mar18_04.jpg\" alt=\"\" width=\"400\" height=\"264\" srcset=\"https:\/\/d1xe7tfg0uwul9.cloudfront.net\/sbpt.org.br\/portal\/wp-content\/uploads\/2018\/05\/caso03_mar18_04.jpg 400w, https:\/\/d1xe7tfg0uwul9.cloudfront.net\/sbpt.org.br\/portal\/wp-content\/uploads\/2018\/05\/caso03_mar18_04-300x198.jpg 300w\" sizes=\"auto, (max-width: 400px) 100vw, 400px\" \/><figcaption id=\"caption-attachment-9899\" class=\"wp-caption-text\">Figura 4<\/figcaption><\/figure>\n<p>&nbsp;<\/p>\n<figure id=\"attachment_9900\" aria-describedby=\"caption-attachment-9900\" style=\"width: 400px\" class=\"wp-caption aligncenter\"><img loading=\"lazy\" decoding=\"async\" class=\"size-full wp-image-9900\" src=\"https:\/\/d1xe7tfg0uwul9.cloudfront.net\/sbpt.org.br\/portal\/wp-content\/uploads\/2018\/05\/caso03_mar18_05.jpg\" alt=\"\" width=\"400\" height=\"278\" srcset=\"https:\/\/d1xe7tfg0uwul9.cloudfront.net\/sbpt.org.br\/portal\/wp-content\/uploads\/2018\/05\/caso03_mar18_05.jpg 400w, https:\/\/d1xe7tfg0uwul9.cloudfront.net\/sbpt.org.br\/portal\/wp-content\/uploads\/2018\/05\/caso03_mar18_05-300x209.jpg 300w\" sizes=\"auto, (max-width: 400px) 100vw, 400px\" \/><figcaption id=\"caption-attachment-9900\" class=\"wp-caption-text\">Figura 5<\/figcaption><\/figure>\n<p>&nbsp;<\/p>\n<figure id=\"attachment_9901\" aria-describedby=\"caption-attachment-9901\" style=\"width: 400px\" class=\"wp-caption aligncenter\"><img loading=\"lazy\" decoding=\"async\" class=\"size-full wp-image-9901\" src=\"https:\/\/d1xe7tfg0uwul9.cloudfront.net\/sbpt.org.br\/portal\/wp-content\/uploads\/2018\/05\/caso03_mar18_06.jpg\" alt=\"\" width=\"400\" height=\"293\" srcset=\"https:\/\/d1xe7tfg0uwul9.cloudfront.net\/sbpt.org.br\/portal\/wp-content\/uploads\/2018\/05\/caso03_mar18_06.jpg 400w, https:\/\/d1xe7tfg0uwul9.cloudfront.net\/sbpt.org.br\/portal\/wp-content\/uploads\/2018\/05\/caso03_mar18_06-300x220.jpg 300w\" sizes=\"auto, (max-width: 400px) 100vw, 400px\" \/><figcaption id=\"caption-attachment-9901\" class=\"wp-caption-text\">Figura 6<\/figcaption><\/figure>\n<p>&nbsp;<\/p>\n<figure id=\"attachment_9902\" aria-describedby=\"caption-attachment-9902\" style=\"width: 400px\" class=\"wp-caption aligncenter\"><img loading=\"lazy\" decoding=\"async\" class=\"size-full wp-image-9902\" src=\"https:\/\/d1xe7tfg0uwul9.cloudfront.net\/sbpt.org.br\/portal\/wp-content\/uploads\/2018\/05\/caso03_mar18_07.jpg\" alt=\"\" width=\"400\" height=\"299\" srcset=\"https:\/\/d1xe7tfg0uwul9.cloudfront.net\/sbpt.org.br\/portal\/wp-content\/uploads\/2018\/05\/caso03_mar18_07.jpg 400w, https:\/\/d1xe7tfg0uwul9.cloudfront.net\/sbpt.org.br\/portal\/wp-content\/uploads\/2018\/05\/caso03_mar18_07-300x224.jpg 300w\" sizes=\"auto, (max-width: 400px) 100vw, 400px\" \/><figcaption id=\"caption-attachment-9902\" class=\"wp-caption-text\">Figura 7<\/figcaption><\/figure>\n<p>&nbsp;<\/p>\n<p><strong>Quest\u00e3o \u2013 Dada a sua condi\u00e7\u00e3o cl\u00ednica, o seu hist\u00f3rico m\u00e9dico pregresso e os seus exames complementares, qual a estrat\u00e9gia terap\u00eautica mais adequada para a paciente em quest\u00e3o?<\/strong><\/p>\n<p>(a) &#8211; Modificar tratamento para LABA+LAMA+ICS.<br \/>\n(b) &#8211; Cirurgia redutora de volume pulmonar.<br \/>\n(c) &#8211; Tratamento endosc\u00f3pico com v\u00e1lvulas endobr\u00f4nquicas.<br \/>\n(d) &#8211; Manter Formoterol + Budesonida e Reabilita\u00e7\u00e3o Pulmonar.<br \/>\n(e) &#8211; Modificar tratamento para LABA+LAMA e reabilita\u00e7\u00e3o pulmonar.<\/p>\n<p>&nbsp;<\/p>\n<p><strong>Discuss\u00e3o da op\u00e7\u00e3o A \u2013 O benef\u00edcio question\u00e1vel da utiliza\u00e7\u00e3o de corticosteroides inal\u00e1veis.<\/strong><\/p>\n<p>A iniciativa GOLD \u2013 2018 (Global Initiative for Chronic Obstructive Lung Disease) recomenda a utiliza\u00e7\u00e3o de broncodilatadores de a\u00e7\u00e3o curta para todos os grupos de pacientes estratificados conforme a gravidade da doen\u00e7a. Al\u00e9m disso, a utiliza\u00e7\u00e3o combinada de broncodilatadores LABA + LAMA \u00e9 indicada para pacientes com dispneia intensa, mas baixo risco de ocorr\u00eancia de exacerba\u00e7\u00e3o, sempre levando em conta a disponibilidade do tratamento, os efeitos colaterais e a resposta individual. A recomenda\u00e7\u00e3o de corticosteroides inalat\u00f3rios se restringe, de forma geral, a pacientes que possuam altos riscos de desenvolvimento de exacerba\u00e7\u00e3o (Fernandes et al., 2017).<\/p>\n<p>O quadro clinico apresentado pela paciente favorece a escolha terap\u00eautica de combina\u00e7\u00e3o de broncodilatadores LABA + LAMA em fun\u00e7\u00e3o da dispneia intensa (MRC 3). Os principais benef\u00edcios obtidos com essa abordagem incluem a melhora do estado geral de sa\u00fade, o incremento da capacidade funcional, o aumento da toler\u00e2ncia ao exerc\u00edcio, a redu\u00e7\u00e3o da progress\u00e3o da doen\u00e7a e a redu\u00e7\u00e3o da mortalidade associada.<\/p>\n<p>De forma contr\u00e1ria, ainda que a paciente apresente, em seu hist\u00f3rico m\u00e9dico pregresso, um epis\u00f3dio de exacerba\u00e7\u00e3o com necessidade de antibioticoterapia, dentro de todo o espectro de desenvolvimento de sua doen\u00e7a, n\u00e3o h\u00e1 uma tend\u00eancia clara para a ocorr\u00eancia frequente de exacerba\u00e7\u00f5es.<br \/>\nDessa forma, refutamos a possibilidade de manuten\u00e7\u00e3o de administra\u00e7\u00e3o de corticoides inalat\u00f3rios (CI).<\/p>\n<p><strong>Discuss\u00e3o da op\u00e7\u00e3o B \u2013 Indica\u00e7\u00f5es, benef\u00edcios e riscos da cirurgia redutora de volume pulmonar (CRVP).<\/strong><\/p>\n<p>Os crit\u00e9rios de indica\u00e7\u00e3o para a realiza\u00e7\u00e3o da CRVP (National Emphysema Treatment Trial Research Group, 2003) da paciente incluem: idade inferior a 75 anos, ex-fumante h\u00e1 mais de seis meses, caracteriza\u00e7\u00e3o cl\u00ednica de enfisema, hiperinsufla\u00e7\u00e3o pulmonar constatada em radiografia de t\u00f3rax, TC de alta resolu\u00e7\u00e3o evidenciando enfisema especialmente nos lobos superiores.<\/p>\n<p>Devemos observar, no entanto, que segundo o mesmo estudo (National Emphysema Treatment Trial Research Group, 2003) a paciente n\u00e3o cumpriu crit\u00e9rios importantes para indica\u00e7\u00e3o de tratamento invasivo, a saber: manuten\u00e7\u00e3o da dispneia a despeito de terapia medicamentosa m\u00e1xima e ter realizado um PRP.<\/p>\n<p>Dessa forma, embora tenha crit\u00e9rio de imagem para CRVP, ainda n\u00e3o est\u00e1 com broncodilata\u00e7\u00e3o m\u00e1xima e nem realizou reabilita\u00e7\u00e3o pulmonar. Portanto, descartou-se a possibilidade de realizar a CRVP num primeiro momento.<\/p>\n<p><strong>Discuss\u00e3o da op\u00e7\u00e3o C \u2013 Indica\u00e7\u00f5es, benef\u00edcios e riscos do tratamento endosc\u00f3pico com v\u00e1lvulas endobr\u00f4nquicas.<\/strong><\/p>\n<p>Embora o tratamento endosc\u00f3pico com v\u00e1lvulas se apresente como uma possibilidade terap\u00eautica para pacientes com DPOC e enfisema severo, a terapia medicamentosa, a reabilita\u00e7\u00e3o pulmonar e a cessa\u00e7\u00e3o do tabagismo continuam sendo a base da terap\u00eautica para esses pacientes (Eberhardt, Gompelmann, Herth &amp; Schumann, 2015).<\/p>\n<p>Pacientes que se apresentam como poss\u00edveis candidatos para o tratamento com v\u00e1lvulas endobr\u00f4nquicas devem ter um VEF1 &lt; 40% (do previsto) e um quadro de hiperinsufla\u00e7\u00e3o severa com VR &gt; 200% (do previsto). Al\u00e9m disso, comorbidades que podem resultar em risco devem ser levadas em considera\u00e7\u00e3o (Eberhardt et al., 2015). Segundo esses crit\u00e9rios, a paciente ainda n\u00e3o se enquadraria na popula\u00e7\u00e3o indicada para a realiza\u00e7\u00e3o desse procedimento.<\/p>\n<p>Da mesma forma que foi considerado para o tratamento com CRVP, uma abordagem inicial mais racional envolveria o emprego de t\u00e9cnicas terap\u00eauticas menos invasivas e de menor risco para a paciente. Dessa forma, descartamos a possibilidade de realiza\u00e7\u00e3o de tratamento endosc\u00f3pico com v\u00e1lvulas endobr\u00f4nquicas num momento inicial.<\/p>\n<p><strong>Discuss\u00e3o da op\u00e7\u00e3o D \u2013 Abordagem padronizada com PRP e com farmacoterapia usual: v\u00e1lido em todos os casos?<\/strong><\/p>\n<p>Ainda que uma abordagem terap\u00eautica para pacientes com DPOC deva incluir a reabilita\u00e7\u00e3o pulmonar associada ao tratamento farmacol\u00f3gico, v\u00e1rios estudos demonstram que mais de 50% dos pacientes GOLD A utilizam a combina\u00e7\u00e3o de LABA + ICS sem necessidade. Desta forma, a terap\u00eautica seguindo os princ\u00edpios da medicina personalizada seria muito mais vantajosa.<br \/>\nConforme discutido previamente, a utiliza\u00e7\u00e3o de CI em pacientes sem risco elevado de exacerba\u00e7\u00e3o parece n\u00e3o ser vantajosa. Dessa forma, descartamos a abordagem com essa classe medicamentosa para a paciente.<\/p>\n<p>A terapia medicamentosa com broncodilatadores de a\u00e7\u00e3o longa \u00e9 a base do tratamento para pacientes com DPOC. A combina\u00e7\u00e3o desses medicamentos, mas de classes farmacol\u00f3gicas distintas, tem-se mostrado mais eficaz que a monoterapia (Anzueto &amp; Miravitlles, 2018). Dessa forma, a farmacoterapia mais racional para esse caso seria a baseada na combina\u00e7\u00e3o de duas classes diferentes de broncodilatadores, em detrimento da utiliza\u00e7\u00e3o de somente um representante.<\/p>\n<p>Um estudo realizado na Espanha demonstrou que tabagistas com n\u00edvel elevado de atividade f\u00edsica demoravam mais tempo para apresentar dispneia e para a primeira interna\u00e7\u00e3o hospitalar (Garcya-Almerich, Lange, Benet, Schnohr &amp; Ant\u00f3, 2006). Da mesma forma, uma ampla base de evid\u00eancia demonstra as vantagens da reabilita\u00e7\u00e3o pulmonar na melhora da dispneia, sintoma cardinal e de causa multifatorial na DPOC, redu\u00e7\u00e3o das exacerba\u00e7\u00f5es e do n\u00famero de interna\u00e7\u00f5es hospitalares, menor utiliza\u00e7\u00e3o dos servi\u00e7os de sa\u00fade e melhora nas atividades de vida di\u00e1ria, melhora na qualidade de vida e redu\u00e7\u00e3o na mortalidade (Celli, Stoller &amp; Hollingsworth, 2017; Puhan, Scharplatz, Troosters &amp; Steurer, 2005).<\/p>\n<p><strong>Abordagem terap\u00eautica adotada no caso: LABA + LAMA e reabilita\u00e7\u00e3o pulmonar.<\/strong><\/p>\n<p>A paciente foi inclu\u00edda num programa de reabilita\u00e7\u00e3o pulmonar envolvendo avalia\u00e7\u00e3o m\u00e9dica, fisioterap\u00eautica, nutricional e psicol\u00f3gica, composto por 24 sess\u00f5es de treinamento f\u00edsico, al\u00e9m de uma sess\u00e3o semanal de grupo com psiquiatria.<\/p>\n<p>Em avalia\u00e7\u00e3o inicial, a paciente realizou teste de caminhada de seis minutos e ergoespirometria, cuja curva fluxo\/volume abaixo demonstra a presen\u00e7a de hiperinsufla\u00e7\u00e3o de 500 ml no pico do exerc\u00edcio. A paciente tamb\u00e9m foi submetida \u00e0 aplica\u00e7\u00e3o do question\u00e1rio do hospital Saint George para doen\u00e7a respirat\u00f3ria (SGRQ) para avalia\u00e7\u00e3o da qualidade de vida.<\/p>\n<p>1) &#8211; Curvas de fluxo \u2013 volume demonstrando hiperinsufla\u00e7\u00e3o durante o exerc\u00edcio e queda de 0.5 L (2.21 L no in\u00edcio do exerc\u00edcio; 1.71 L no pico do exerc\u00edcio) do volume inspirat\u00f3rio:<\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"size-full wp-image-9903\" src=\"https:\/\/d1xe7tfg0uwul9.cloudfront.net\/sbpt.org.br\/portal\/wp-content\/uploads\/2018\/05\/caso03_mar18_08.jpg\" alt=\"\" width=\"647\" height=\"360\" srcset=\"https:\/\/d1xe7tfg0uwul9.cloudfront.net\/sbpt.org.br\/portal\/wp-content\/uploads\/2018\/05\/caso03_mar18_08.jpg 647w, https:\/\/d1xe7tfg0uwul9.cloudfront.net\/sbpt.org.br\/portal\/wp-content\/uploads\/2018\/05\/caso03_mar18_08-300x167.jpg 300w\" sizes=\"auto, (max-width: 647px) 100vw, 647px\" \/><\/p>\n<p>&nbsp;<\/p>\n<p><strong>Avalia\u00e7\u00e3o da resposta terap\u00eautica<\/strong><\/p>\n<p>Os resultados obtidos pela paciente ap\u00f3s a realiza\u00e7\u00e3o das 24 sess\u00f5es de treinamento f\u00edsico e demais componentes do PRP e a farmacoterapia combinada de broncodilatadores encontram-se na tabela a seguir.<\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"aligncenter size-full wp-image-9904\" src=\"https:\/\/d1xe7tfg0uwul9.cloudfront.net\/sbpt.org.br\/portal\/wp-content\/uploads\/2018\/05\/caso03_mar18_09.jpg\" alt=\"\" width=\"742\" height=\"137\" srcset=\"https:\/\/d1xe7tfg0uwul9.cloudfront.net\/sbpt.org.br\/portal\/wp-content\/uploads\/2018\/05\/caso03_mar18_09.jpg 742w, https:\/\/d1xe7tfg0uwul9.cloudfront.net\/sbpt.org.br\/portal\/wp-content\/uploads\/2018\/05\/caso03_mar18_09-300x55.jpg 300w\" sizes=\"auto, (max-width: 742px) 100vw, 742px\" \/><\/p>\n<p>No TC6M, a dist\u00e2ncia percorrida aumentou em 236 metros (aumento de 115%), o n\u00edvel de percep\u00e7\u00e3o de dispneia diminuiu em 1 ponto na escala modificada de Borg e a limita\u00e7\u00e3o imposta pela dispneia medida pela escala MRC diminuiu em 1 ponto, demonstrando a melhora da paciente em termos de incremento de capacidade funcional e ganho de resist\u00eancia ao exerc\u00edcio.<\/p>\n<p>Quanto \u00e0 qualidade de vida da paciente, observamos uma melhora em todos os dom\u00ednios do SGRQ, n\u00e3o sendo clinicamente significativo somente para o dom\u00ednio de atividades, ainda que demonstrando evolu\u00e7\u00e3o positiva. Al\u00e9m disso, observamos que as escalas de ansiedade e de depress\u00e3o de Beck (BAI e BDI, respectivamente) tamb\u00e9m apresentaram melhoras com a abordagem terap\u00eautica empregada.<\/p>\n<p><strong>Referencias Bibliogr\u00e1ficas<\/strong><\/p>\n<p>1. Global Initiative for Chronic Obstructive Lung Disease (GOLD): Global Strategy for the Diagnosis, Management, and Prevention of COPD 2018.<a href=\"http:\/\/www.goldcopd.org\" target=\"_blank\" rel=\"noopener\"> www.goldcopd.org<\/a> (Accessed on March 22, 2018).<\/p>\n<p>2. SCIURBA, Frank C. et al. A randomized study of endobronchial valves for advanced emphysema. New Engl J Med 2010; 363(13): 1233-1244.<\/p>\n<p>3. FERNANDES, Frederico Leon Arrabal et al. Recommendations for the pharmacological treatment of COPD: questions and answers. J. Bras. Pneumol. 2017; 43(4): 290-301.<\/p>\n<p>4. NATIONAL EMPHYSEMA TREATMENT TRIAL RESEARCH GROUP. A randomized trial comparing lung-volume\u2013reduction surgery with medical therapy for severe emphysema. New Engl J Med 2003; 348(21): 2059-2073.<\/p>\n<p>5. EBERHARDT, Ralf et al. Endoscopic bronchial valve treatment: patient selection and special considerations. Int J Chron Obstruct Pulmon Dis. 2015; 10: 2147-57.<\/p>\n<p>6. ANZUETO, Antonio; MIRAVITLLES, Marc. The Role of Fixed-Dose Dual Bronchodilator Therapy in Treating COPD. Am J Med, 2018.<\/p>\n<p>7. Bartolome R Celli. Pulmonary rehabilitation. Post TW, ed. UpToDate. Waltham, MA: UpToDate Inc. <a href=\"http:\/\/www.uptodate.com\" target=\"_blank\" rel=\"noopener\">http:\/\/www.uptodate.com<\/a> (Accessed on March 27, 2018.).<\/p>\n<p>8. PUHAN, Milo A. et al. Respiratory rehabilitation after acute exacerbation of COPD may reduce risk for readmission and mortality\u2013a systematic review. Respir. Res. 2005; 6(1): 54.<\/p>\n<p>9. MCCARTHY, Bernard et al. Pulmonary rehabilitation for chronic obstructive pulmonary disease. Cochrane Database Sys Rev, 2015.<\/p>\n<p>10. NATIONAL EMPHYSEMA TREATMENT TRIAL RESEARCH GROUP. A randomized trial comparing lung-volume\u2013reduction surgery with medical therapy for severe emphysema. New Engl J Med 2003; 348(21): 2059-73.<\/p>\n<p>11. GARCIA-AYMERICH, Judith et al. Regular physical activity reduces hospital admission and mortality in chronic obstructive pulmonary disease: a population based cohort study. Thorax 2006; 61(9): 772-778.<\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<p>Resposta \u00e0 quest\u00e3o: E<\/p>\n","protected":false},"excerpt":{"rendered":"Discutindo o tratamento farmacol\u00f3gico da DPOC Autores Dr. Paulo Jos\u00e9 Zimmermann Teixeira \u2013 Professor da Faculdade de Medicina da UFCSPA. Marcelo Ferreira Nogueira \u2013 Residente em Pneumologia da ISCMPA. Mateus Henrique Schneider \u2013 Acad\u00eamico da Faculdade de Medicina da UFCSPA. Relato do Caso Parte 1 Paciente feminina, 73 anos, ex-tabagista (fumou dos 13 aos 63 [\u2026]","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"ngg_post_thumbnail":0,"footnotes":""},"categories":[15,217],"tags":[],"class_list":["post-9891","post","type-post","status-publish","format-standard","hentry","category-acesso-restrito","category-casos-clinicos-2018"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.7 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Caso cl\u00ednico \u2013 Mar\u00e7o 2018 - sbpt.org.br<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/sbpt.org.br\/portal\/caso-clinico-marco-2018\/\" \/>\n<meta property=\"og:locale\" content=\"pt_BR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Caso cl\u00ednico \u2013 Mar\u00e7o 2018 - sbpt.org.br\" \/>\n<meta property=\"og:description\" content=\"Discutindo o tratamento farmacol\u00f3gico da DPOC Autores Dr. Paulo Jos\u00e9 Zimmermann Teixeira \u2013 Professor da Faculdade de Medicina da UFCSPA. Marcelo Ferreira Nogueira \u2013 Residente em Pneumologia da ISCMPA. Mateus Henrique Schneider \u2013 Acad\u00eamico da Faculdade de Medicina da UFCSPA. Relato do Caso Parte 1 Paciente feminina, 73 anos, ex-tabagista (fumou dos 13 aos 63 [\u2026]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/sbpt.org.br\/portal\/caso-clinico-marco-2018\/\" \/>\n<meta property=\"og:site_name\" content=\"sbpt.org.br\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/pneumosbpt\" \/>\n<meta property=\"article:published_time\" content=\"2018-05-03T15:23:10+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/sbpt.org.br\/portal\/wp-content\/uploads\/2018\/05\/caso03_mar18_01.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"400\" \/>\n\t<meta property=\"og:image:height\" content=\"328\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Paulo Campos\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@pneumosbpt\" \/>\n<meta name=\"twitter:site\" content=\"@pneumosbpt\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"Paulo Campos\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. tempo de leitura\" \/>\n\t<meta name=\"twitter:data2\" content=\"9 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/sbpt.org.br\\\/portal\\\/caso-clinico-marco-2018\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/sbpt.org.br\\\/portal\\\/caso-clinico-marco-2018\\\/\"},\"author\":{\"name\":\"Paulo Campos\",\"@id\":\"https:\\\/\\\/sbpt.org.br\\\/portal\\\/#\\\/schema\\\/person\\\/25d1c6e4a25f0333d9e675d8043837f6\"},\"headline\":\"Caso cl\u00ednico \u2013 Mar\u00e7o 2018\",\"datePublished\":\"2018-05-03T15:23:10+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/sbpt.org.br\\\/portal\\\/caso-clinico-marco-2018\\\/\"},\"wordCount\":1856,\"publisher\":{\"@id\":\"https:\\\/\\\/sbpt.org.br\\\/portal\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/sbpt.org.br\\\/portal\\\/caso-clinico-marco-2018\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/d1xe7tfg0uwul9.cloudfront.net\\\/sbpt-portal\\\/wp-content\\\/uploads\\\/2018\\\/05\\\/caso03_mar18_01.jpg\",\"articleSection\":[\"Acesso Restrito\",\"Casos Cl\u00ednicos \u2013 2018\"],\"inLanguage\":\"pt-BR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/sbpt.org.br\\\/portal\\\/caso-clinico-marco-2018\\\/\",\"url\":\"https:\\\/\\\/sbpt.org.br\\\/portal\\\/caso-clinico-marco-2018\\\/\",\"name\":\"Caso cl\u00ednico \u2013 Mar\u00e7o 2018 - sbpt.org.br\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/sbpt.org.br\\\/portal\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/sbpt.org.br\\\/portal\\\/caso-clinico-marco-2018\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/sbpt.org.br\\\/portal\\\/caso-clinico-marco-2018\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/d1xe7tfg0uwul9.cloudfront.net\\\/sbpt-portal\\\/wp-content\\\/uploads\\\/2018\\\/05\\\/caso03_mar18_01.jpg\",\"datePublished\":\"2018-05-03T15:23:10+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/sbpt.org.br\\\/portal\\\/caso-clinico-marco-2018\\\/#breadcrumb\"},\"inLanguage\":\"pt-BR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/sbpt.org.br\\\/portal\\\/caso-clinico-marco-2018\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\\\/\\\/sbpt.org.br\\\/portal\\\/caso-clinico-marco-2018\\\/#primaryimage\",\"url\":\"https:\\\/\\\/d1xe7tfg0uwul9.cloudfront.net\\\/sbpt-portal\\\/wp-content\\\/uploads\\\/2018\\\/05\\\/caso03_mar18_01.jpg\",\"contentUrl\":\"https:\\\/\\\/d1xe7tfg0uwul9.cloudfront.net\\\/sbpt-portal\\\/wp-content\\\/uploads\\\/2018\\\/05\\\/caso03_mar18_01.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/sbpt.org.br\\\/portal\\\/caso-clinico-marco-2018\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/sbpt.org.br\\\/portal\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Caso cl\u00ednico \u2013 Mar\u00e7o 2018\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/sbpt.org.br\\\/portal\\\/#website\",\"url\":\"https:\\\/\\\/sbpt.org.br\\\/portal\\\/\",\"name\":\"sbpt.org.br\",\"description\":\"Sociedade Brasileira de Pneumologia e Tisiologia\",\"publisher\":{\"@id\":\"https:\\\/\\\/sbpt.org.br\\\/portal\\\/#organization\"},\"alternateName\":\"SBPT\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/sbpt.org.br\\\/portal\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"pt-BR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/sbpt.org.br\\\/portal\\\/#organization\",\"name\":\"sbpt.org.br\",\"url\":\"https:\\\/\\\/sbpt.org.br\\\/portal\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\\\/\\\/sbpt.org.br\\\/portal\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/sbpt.org.br\\\/portal\\\/wp-content\\\/uploads\\\/2026\\\/10\\\/logo-sbpt.png\",\"contentUrl\":\"https:\\\/\\\/sbpt.org.br\\\/portal\\\/wp-content\\\/uploads\\\/2026\\\/10\\\/logo-sbpt.png\",\"width\":512,\"height\":512,\"caption\":\"sbpt.org.br\"},\"image\":{\"@id\":\"https:\\\/\\\/sbpt.org.br\\\/portal\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/pneumosbpt\",\"https:\\\/\\\/x.com\\\/pneumosbpt\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/pneumosbpt\\\/\",\"https:\\\/\\\/www.instagram.com\\\/pneumosbpt\\\/\",\"https:\\\/\\\/www.youtube.com\\\/user\\\/socbraspneumol\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/sbpt.org.br\\\/portal\\\/#\\\/schema\\\/person\\\/25d1c6e4a25f0333d9e675d8043837f6\",\"name\":\"Paulo Campos\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/68136167da57c9f55271c7cedabfa948fa7cf47517ec6429c6ae3f6a2c732f45?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/68136167da57c9f55271c7cedabfa948fa7cf47517ec6429c6ae3f6a2c732f45?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/68136167da57c9f55271c7cedabfa948fa7cf47517ec6429c6ae3f6a2c732f45?s=96&d=mm&r=g\",\"caption\":\"Paulo Campos\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Caso cl\u00ednico \u2013 Mar\u00e7o 2018 - sbpt.org.br","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/sbpt.org.br\/portal\/caso-clinico-marco-2018\/","og_locale":"pt_BR","og_type":"article","og_title":"Caso cl\u00ednico \u2013 Mar\u00e7o 2018 - sbpt.org.br","og_description":"Discutindo o tratamento farmacol\u00f3gico da DPOC Autores Dr. Paulo Jos\u00e9 Zimmermann Teixeira \u2013 Professor da Faculdade de Medicina da UFCSPA. Marcelo Ferreira Nogueira \u2013 Residente em Pneumologia da ISCMPA. Mateus Henrique Schneider \u2013 Acad\u00eamico da Faculdade de Medicina da UFCSPA. Relato do Caso Parte 1 Paciente feminina, 73 anos, ex-tabagista (fumou dos 13 aos 63 [\u2026]","og_url":"https:\/\/sbpt.org.br\/portal\/caso-clinico-marco-2018\/","og_site_name":"sbpt.org.br","article_publisher":"https:\/\/www.facebook.com\/pneumosbpt","article_published_time":"2018-05-03T15:23:10+00:00","og_image":[{"width":400,"height":328,"url":"https:\/\/sbpt.org.br\/portal\/wp-content\/uploads\/2018\/05\/caso03_mar18_01.jpg","type":"image\/jpeg"}],"author":"Paulo Campos","twitter_card":"summary_large_image","twitter_creator":"@pneumosbpt","twitter_site":"@pneumosbpt","twitter_misc":{"Escrito por":"Paulo Campos","Est. tempo de leitura":"9 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/sbpt.org.br\/portal\/caso-clinico-marco-2018\/#article","isPartOf":{"@id":"https:\/\/sbpt.org.br\/portal\/caso-clinico-marco-2018\/"},"author":{"name":"Paulo Campos","@id":"https:\/\/sbpt.org.br\/portal\/#\/schema\/person\/25d1c6e4a25f0333d9e675d8043837f6"},"headline":"Caso cl\u00ednico \u2013 Mar\u00e7o 2018","datePublished":"2018-05-03T15:23:10+00:00","mainEntityOfPage":{"@id":"https:\/\/sbpt.org.br\/portal\/caso-clinico-marco-2018\/"},"wordCount":1856,"publisher":{"@id":"https:\/\/sbpt.org.br\/portal\/#organization"},"image":{"@id":"https:\/\/sbpt.org.br\/portal\/caso-clinico-marco-2018\/#primaryimage"},"thumbnailUrl":"https:\/\/d1xe7tfg0uwul9.cloudfront.net\/sbpt-portal\/wp-content\/uploads\/2018\/05\/caso03_mar18_01.jpg","articleSection":["Acesso Restrito","Casos Cl\u00ednicos \u2013 2018"],"inLanguage":"pt-BR"},{"@type":"WebPage","@id":"https:\/\/sbpt.org.br\/portal\/caso-clinico-marco-2018\/","url":"https:\/\/sbpt.org.br\/portal\/caso-clinico-marco-2018\/","name":"Caso cl\u00ednico \u2013 Mar\u00e7o 2018 - sbpt.org.br","isPartOf":{"@id":"https:\/\/sbpt.org.br\/portal\/#website"},"primaryImageOfPage":{"@id":"https:\/\/sbpt.org.br\/portal\/caso-clinico-marco-2018\/#primaryimage"},"image":{"@id":"https:\/\/sbpt.org.br\/portal\/caso-clinico-marco-2018\/#primaryimage"},"thumbnailUrl":"https:\/\/d1xe7tfg0uwul9.cloudfront.net\/sbpt-portal\/wp-content\/uploads\/2018\/05\/caso03_mar18_01.jpg","datePublished":"2018-05-03T15:23:10+00:00","breadcrumb":{"@id":"https:\/\/sbpt.org.br\/portal\/caso-clinico-marco-2018\/#breadcrumb"},"inLanguage":"pt-BR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/sbpt.org.br\/portal\/caso-clinico-marco-2018\/"]}]},{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/sbpt.org.br\/portal\/caso-clinico-marco-2018\/#primaryimage","url":"https:\/\/d1xe7tfg0uwul9.cloudfront.net\/sbpt-portal\/wp-content\/uploads\/2018\/05\/caso03_mar18_01.jpg","contentUrl":"https:\/\/d1xe7tfg0uwul9.cloudfront.net\/sbpt-portal\/wp-content\/uploads\/2018\/05\/caso03_mar18_01.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/sbpt.org.br\/portal\/caso-clinico-marco-2018\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/sbpt.org.br\/portal\/"},{"@type":"ListItem","position":2,"name":"Caso cl\u00ednico \u2013 Mar\u00e7o 2018"}]},{"@type":"WebSite","@id":"https:\/\/sbpt.org.br\/portal\/#website","url":"https:\/\/sbpt.org.br\/portal\/","name":"sbpt.org.br","description":"Sociedade Brasileira de Pneumologia e Tisiologia","publisher":{"@id":"https:\/\/sbpt.org.br\/portal\/#organization"},"alternateName":"SBPT","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/sbpt.org.br\/portal\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"pt-BR"},{"@type":"Organization","@id":"https:\/\/sbpt.org.br\/portal\/#organization","name":"sbpt.org.br","url":"https:\/\/sbpt.org.br\/portal\/","logo":{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/sbpt.org.br\/portal\/#\/schema\/logo\/image\/","url":"https:\/\/sbpt.org.br\/portal\/wp-content\/uploads\/2026\/10\/logo-sbpt.png","contentUrl":"https:\/\/sbpt.org.br\/portal\/wp-content\/uploads\/2026\/10\/logo-sbpt.png","width":512,"height":512,"caption":"sbpt.org.br"},"image":{"@id":"https:\/\/sbpt.org.br\/portal\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/pneumosbpt","https:\/\/x.com\/pneumosbpt","https:\/\/www.linkedin.com\/company\/pneumosbpt\/","https:\/\/www.instagram.com\/pneumosbpt\/","https:\/\/www.youtube.com\/user\/socbraspneumol"]},{"@type":"Person","@id":"https:\/\/sbpt.org.br\/portal\/#\/schema\/person\/25d1c6e4a25f0333d9e675d8043837f6","name":"Paulo Campos","image":{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/secure.gravatar.com\/avatar\/68136167da57c9f55271c7cedabfa948fa7cf47517ec6429c6ae3f6a2c732f45?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/68136167da57c9f55271c7cedabfa948fa7cf47517ec6429c6ae3f6a2c732f45?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/68136167da57c9f55271c7cedabfa948fa7cf47517ec6429c6ae3f6a2c732f45?s=96&d=mm&r=g","caption":"Paulo Campos"}}]}},"_links":{"self":[{"href":"https:\/\/sbpt.org.br\/portal\/wp-json\/wp\/v2\/posts\/9891","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/sbpt.org.br\/portal\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/sbpt.org.br\/portal\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/sbpt.org.br\/portal\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/sbpt.org.br\/portal\/wp-json\/wp\/v2\/comments?post=9891"}],"version-history":[{"count":0,"href":"https:\/\/sbpt.org.br\/portal\/wp-json\/wp\/v2\/posts\/9891\/revisions"}],"wp:attachment":[{"href":"https:\/\/sbpt.org.br\/portal\/wp-json\/wp\/v2\/media?parent=9891"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/sbpt.org.br\/portal\/wp-json\/wp\/v2\/categories?post=9891"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/sbpt.org.br\/portal\/wp-json\/wp\/v2\/tags?post=9891"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}